Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.48 |
| ▸ | HPGD | P15428 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1462546 | 0.78 | MAPT (0.56) | MAPTHPGDALDH1A1LMNAKMT2A | |
| SCHEMBL7518002 | 0.78 | MAPT (0.50) | MAPTHPGDALDH1A1LMNAKMT2A | |
| Hydrochloric Acid SCHEMBL11852203 | 0.76 | MAPT (0.48) | MAPTHPGDALDH1A1LMNAKMT2A | |
| SCHEMBL7162336 | 0.76 | MAPT (0.43) | MAPTHPGDALDH1A1LMNAKMT2A | |
| SCHEMBL10427648 | 0.76 | MAPT (0.48) | MAPTHPGDALDH1A1LMNAKMT2A | |
| SCHEMBL5847804 | 0.76 | CES2 (0.42) | MAPTHPGDALDH1A1KMT2AHTT | |
| SCHEMBL10783553 | 0.76 | SMN1; SMN2 (0.45) | MAPTALDH1A1KMT2ACES2CES1 | |
| SCHEMBL11568437 | 0.76 | HPGD (0.51) | MAPTHPGDALDH1A1LMNACES2 | |
| SCHEMBL10779121 | 0.76 | ALDH1A1 (0.50) | MAPTHPGDALDH1A1LMNAKMT2A | |
| SCHEMBL979444 | 0.75 | FFAR1 (0.44) | MAPTHPGDALDH1A1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4551545-A | Process of preparing alkyl cis chrysanthemates | ROUSSEL UCLAF (FR) | 1985-11-05 | — | — | US | claimed |
| JP-5025090-A | — | — | None | — | — | JP | disclosed |
| US-20250059227-A1 | ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE OF SAME | RIKEN GENESIS CO., LTD. (JP) | 2025-02-20 | — | — | US | disclosed |
| EP-4458836-A1 | NOVEL ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE OF SAME | Riken Genesis Co., Ltd. (JP) | 2024-11-06 | — | — | EP | disclosed |
| WO-2023127857-A1 | NOVEL ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE OF SAME | 株式会社理研ジェネシス | 2023-07-06 | — | — | WO | disclosed |
| US-6350863-B1 | RIBOFURANOSE SUBSTITUTED WITH 2 BENZYLAMINES FORMED BY REACTION OF 1-BROMO-3,4-DIAMINOBENZENE AND 1,2-BIS/CHLORO DIMETHYSILYLETHANE | CANON KABUSHIKI KAISHA (JP) | 2002-02-26 | — | — | US | disclosed |
| US-6011143-A | Artificial nucleic acids and a method of making | CANON KABUSHIKI KAISHA (JP) | 2000-01-04 | — | — | US | disclosed |
| JP-H0525090-A | INTERMEDIATE COMPOUND FOR PRODUCING ALKYL CIS-CHRYSANTHEMATE | ROUSSEL UCLAF | 1993-02-02 | — | — | JP | disclosed |
| EP-0280927-B1 | MONO- AND DIEPOXIDE DERIVATIVES OF DELTA 22-LL-F28249 COMPOUNDS | AMERICAN CYANAMID COMPANY (US) | 1992-06-10 | — | — | EP | disclosed |
| US-4946852-A | ANTICHOLESTEROL AGENT | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-08-07 | — | — | US | disclosed |
| US-4695644-A | Process for producing phenyl chlorothioformates | TOYO SODA MANUFACTURING CO., LTD. (JP) | 1987-09-22 | — | — | US | disclosed |
| US-4677218-A | INSECTICIDES | ROUSSEL UCLAF (FR) | 1987-06-30 | — | — | US | disclosed |
| US-4551545-A | Process of preparing alkyl cis chrysanthemates | ROUSSEL UCLAF (FR) | 1985-11-05 | — | — | US | disclosed |
| US-4550160-A | Processes for the interconversion of C-076 compounds | MERCK & CO., INC. (US) | 1985-10-29 | — | — | US | disclosed |
| US-4328335-A | PARASITICIDES, CULTURE PRODUCT OF STREPTOMYCES REACTED WITH A THIOCARBONYL HALIDE | MERCK & CO., INC. (US) | 1982-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059227-A1 | ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE OF SAME | NSUN3, NSUN2, LUC7L2 | MAPT 4381/4885HPGD 4455/4885ALDH1A1 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.